Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer.
Bioconjug Chem. 2022 Feb 16;33(2):418-426. doi: 10.1021/acs.bioconjchem.2c00015. Epub 2022 Feb 1.
Bioconjug Chem. 2022.
PMID: 35104102
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model.
Juen L, Baltus CB, Gély C, Feuillâtre O, Desgranges A, Viaud-Massuard MC, Martin C.
Juen L, et al. Among authors: feuillatre o.
Bioconjug Chem. 2021 Mar 17;32(3):595-606. doi: 10.1021/acs.bioconjchem.1c00058. Epub 2021 Feb 25.
Bioconjug Chem. 2021.
PMID: 33630573
Item in Clipboard
Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody-Drug Conjugates.
Feuillâtre O, Gély C, Huvelle S, Baltus CB, Juen L, Joubert N, Desgranges A, Viaud-Massuard MC, Martin C.
Feuillâtre O, et al.
ACS Omega. 2020 Jan 17;5(3):1557-1565. doi: 10.1021/acsomega.9b03510. eCollection 2020 Jan 28.
ACS Omega. 2020.
PMID: 32010829
Free PMC article.
Item in Clipboard
Cite
Cite